“…We identified 40 studies in the literature that specifically addressed the use of totally ICONB in the treatment of bladder cancer. Among these, the most frequent type of UD described was the Studer “U” modified neobladder (twenty eight studies, 70%) [ [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] ], followed by the Hautmann “W” modified neobladder (three studies, 7.5%) [ 13 , 44 , 45 ], the “Y" neobladder [ 46 , 47 ] and the Padua ICONB (two studies each, 5%) [ 48 , 49 ]. The Camey reservoir [ 50 ], the pyramid pouch [ 51 ], the robot-assisted vescica ileale padovana (ra-VIP) [ 52 ], and the Florence robotic intracorporeal neobladder (FloRIN) urinary diversion [ 53 ] were reported in only one study each.…”